Oncotarget: Leading Oncology Publication

The science of oncology deals with cancer, its symptoms, diagnosis, and treatment. It is one of the most common diseases to be acquired by humans, and it is also incurable. For years, scientists have done experiments on how they can find the cure for the disease. According to scientists, it will still be a long way before they can find a treatment for cancer. Mikhail Blagosklonny and Andrei Gudkov joined together to create an online medical journal, and they explained that the objective why they are putting it online is because they wanted the scientists around the world to work together and formulate a cure for cancer. The two are colleagues at the Roswell Park Cancer Institute, where they work together as oncologists. Listen to an audio podcast of Oncotarget on Itunes.


Mikhail Blagosklonny and Andrei Gudkov found out that there are only a few articles online dealing with oncology. He wanted to create a system that would allow other scientists from around the globe to send their written articles about the disease. Mikhail Blagosklonny and Andrei Gudkov as the publication’s editors in chief will be reviewing the papers submitted to them and determine whether it is acceptable to be published or not. Often, there is a panel of scientists who would be considering the article. It is known as the first peer review online medical journal, and the scientist aims to make sure that all of the data presented are factual. Listen to Oncotarget podcast on Player.FM.

Established in 2010, Oncotarget was initially released to the public once every week. However, after receiving a positive reception from the readers, Oncotarget decided to publish a new article twice every week. These scientific articles will be reviewed by scientists, and when approved, it will appear on the online medical journal portal. Scientists have thanked Mikhail Blagosklonny and Andrei Gudkov for their outstanding invention. They revealed that the introduction of Oncotarget would soon change a lot of lives. Meanwhile, Mikhail Blagosklonny and Andrei Gudkov are optimistic that Oncotarget will become an instrument in the future that will help humans exterminate fatal disease and gain closer to immortality. Mikhail Blagosklonny and Andrei Gudkov are promoting the online medical journal to other people who have not seen it and telling them that they could learn a lot just by reading it.

Read more: http://www.scimagojr.com/journalsearch.php?q=19900191708&tip=sid

Leave a Reply

Your email address will not be published. Required fields are marked *